- Home
- Articles
- us virgislands
- influenza b
Influenza B Articles & Analysis
8 articles found
Currently, recombinant protein vaccines have been widely used in various infectious diseases, such as the prevention of hepatitis B virus (i.e., hepatitis B), tetanus, pertussis, influenza, etc.Monosaccharides are the simplest form of sugars, including glucose, fructose, galactose, etc. ...
Welcome to 2023-2024 season’s respiratory surveillance recap, where we’ll share insights from the most recent respiratory surveillance season, covering three major respiratory viruses: COVID-19, influenza, and RSV. Tracking these illnesses is imperative for maintaining population health because these illnesses significantly impact individual wellbeing and healthcare costs, resource ...
At the start of this year’s respiratory season, we piloted a new model for sharing data with the public that included not only insights on national and regional trends for COVID-19, but also included our data and analysis for our newly launched influenza A and B as well as RSV. Our weekly Respiratory Risk Reports provide insights across the respiratory ...
The antiviral activity of zapnometinib treatment has been demonstrated for influenza virus infection in vivo (Laure et al., 2020; Koch-Heier et al., 2022) and influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in vitro (Laure et al., 2020; Schreiber et al., 2020; Schreiber et al., 2022). Furthermore, zapnometinib has been ...
Application in the treatment of influenza Introduction of influenza Influenza, also called flu or grippe, is an acute viral infection of the upper or lower respiratory tract. ...
In many developing countries throughout the world, infant and child mortality rates are disturbingly high, and acute respiratory infections— in particular pneumonia—are a leading cause of death. As a result, preventing pneumonia is a priority, and the World Health Organization (WHO) and other healthcare institutions are studying a number of vaccines designed to protect against the ...
There are two antigenically distinct lineages of influenza B virus, Yamagata lineage (YL) and Victoria lineage (VL). Since both B lineages have been co-circulating for years, more than 70% of influenza vaccines currently manufactured are quadrivalent consisting of influenza A (H1N1), influenza A ...
That means there are 198 possible combinations of the two genes, and that’s just for influenza type A. There’s also influenza type B. “Universal is the holy grail,” said Dr. ...